RecruitingPHASE1, PHASE2NCT07018752
A Platform Trial Evaluating New Drugs or Combination in R/R Peripheral T-cell Lymphomas
Studying Lymphoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- The Lymphoma Academic Research Organisation
- Principal Investigator
- François LEMONNIER, PrHôpital Henri Mondor - Lymphoid Malignancies Unit
- Intervention
- roginolisib(drug)
- Enrollment
- 49 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2025 – 2030
Study locations (20)
- Institut d'Hématologie de Basse Normandie - Service Hématologie (CHU Hôpital Côte de Nacre), Caen, France
- CHU Estaing - Service Thérapie Cellulaire et Hématologie Clinique, Clermont-Ferrand, France
- Hôpital Henri Mondor - Unité Hémopathies Lymphoïdes, Créteil, France
- CHU Dijon Bourgogne - Service Hématologie Clinique, Dijon, France
- CHU de Grenoble - Service Hématologie, La Tronche, France
- CH du Mans - Centre de Cancérologie de la Sarthe - Service Hématologie, Le Mans, France
- CHU de Lille - Hôpital Claude Huriez - Service des Maladies du Sang, Lille, France
- Institut Paoli Calmettes - Service Hématologie, Marseille, France
- CHU de Montpellier - Département d'Hématologie Clinique, Montpellier, France
- CHU de Nantes - Service Hématologie, Nantes, France
- Hôpital Necker - Service Hématologie Adultes, Paris, France
- CHU de Bordeaux - Hôpital Haut-Lévêque - Centre François Magendie - Service d'Hématologie et Thérapie Cellulaire, Pessac, France
- CHU Lyon-Sud - Hématologie Clinique, Pierre-Bénite, France
- CHU de Poitiers - Hôpital de la Milétrie - Service d'Oncologie Hématologique et Thérapie Cellulaire, Poitiers, France
- CHU Pontchaillou - Hématologie Clinique, Rennes, France
- +5 more locations on ClinicalTrials.gov
Collaborators
iOnctura · AbbVie · Bristol-Myers Squibb
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07018752 on ClinicalTrials.govOther trials for Lymphoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07372352Zeprumetostat, Azacitidine Combined With Lipo-MIT in R/R PTCLThe First Affiliated Hospital of Soochow University
- RECRUITINGPHASE1NCT07198087A Study to Investigate the Pharmacokinetics of Tirabrutinib in Participants With Mild, Moderate, and Severe Hepatic Impairment Compared to Healthy ParticipantsOno Pharmaceutical Co. Ltd
- RECRUITINGNANCT07191431A Clinical Study on the Efficacy and Safety of Methotrexate (MTX) or Thiotepa (for MTX Intolerance) or Temozolomide (TMZ) Combined With Orelabrutinib and Selinexor in Relapsed/Refractory Primary or Secondary Central Nervous System Lymphoma（SELINA）Ruijin Hospital
- RECRUITINGNANCT07058064WATCH (Wearable Artificial inTelligence for Cardiac Function and Health Monitoring)Mayo Clinic
- RECRUITINGPHASE1NCT06699771Phase 1 to Investigate the Safety, Tolerability, and Efficacy of GCC2005 in Patients With R/R NK and T-cell MalignanciesGC Cell Corporation
- RECRUITINGPHASE2NCT06530550PI3K Inhibitors for the Treatment of Relapsed/Refractory Indolent T/NK-cell LymphomasInstitute of Hematology & Blood Diseases Hospital, China
- RECRUITINGNANCT06296368DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology ClinicsUNC Lineberger Comprehensive Cancer Center
- RECRUITINGNANCT06270667Effects of Exercise Training in Survivors of LymphomaNorwegian School of Sport Sciences